AAAAAA

   
Results: 1-20 |
Results: 20
MONITORING OF HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION BY ANALYSIS OF G-ALPHA-16 MESSENGER-RNA AND CD34 SURFACE GLYCOPROTEIN
Authors: PFEILSTOCKER M KARLIC H SALAMON J MUHLBERGER H PAVLOVA B SELIM U STROBL H PITTERMANN E HEINZ R
Citation: M. Pfeilstocker et al., MONITORING OF HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION BY ANALYSIS OF G-ALPHA-16 MESSENGER-RNA AND CD34 SURFACE GLYCOPROTEIN, Annals of hematology, 76(3-4), 1998, pp. 153-158
THE HEMATOPOIESIS SPECIFIC G-PROTEIN ALPHA-SUBUNIT GALE IS EXPRESSED IN MDS AND MPD
Authors: PFEILSTOCKER M KARLIC H RADOLF M PITTERMANN E HEINZ R
Citation: M. Pfeilstocker et al., THE HEMATOPOIESIS SPECIFIC G-PROTEIN ALPHA-SUBUNIT GALE IS EXPRESSED IN MDS AND MPD, British Journal of Haematology, 102(1), 1998, pp. 24-24
IN-VITRO EVOLUTION OF HODGKIN REED-STERNBERG CELLS FROM BONE-MARROW-DERIVED EBV POSITIVE LYMPHOCYTES/
Authors: PAVLOVA B VESELY M MUHLBERGER H KARLIC H STROBL H MOSTL M NOWOTNY H PITTERMANN E HEINZ R
Citation: B. Pavlova et al., IN-VITRO EVOLUTION OF HODGKIN REED-STERNBERG CELLS FROM BONE-MARROW-DERIVED EBV POSITIVE LYMPHOCYTES/, British Journal of Haematology, 102(1), 1998, pp. 117-117
DIFFUSE LARGE B-CELL LYMPHOMA - A CORRELATION BETWEEN PATHOLOGICAL AND CYTOGENETIC RESULTS AND CLINICAL-FEATURES
Authors: HOPFINGER G NOWOTNY H GRUNER H KARLIC G NADER A FORTELNY A VESELY M PITTERMANN E HEINZ R
Citation: G. Hopfinger et al., DIFFUSE LARGE B-CELL LYMPHOMA - A CORRELATION BETWEEN PATHOLOGICAL AND CYTOGENETIC RESULTS AND CLINICAL-FEATURES, British Journal of Haematology, 102(1), 1998, pp. 123-123
G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL
Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35
STROMAL CELLS DERIVED FROM TUMOR FREE BONE-MARROW OF HODGKIN-DISEASE PATIENTS CAN HARBOR HIDDEN PRE-TUMOR CELLS
Authors: PAVLOVA B VESELY M STROBL H MUHLBERGER H KARLIC H PITTERMANN E HEINZ R
Citation: B. Pavlova et al., STROMAL CELLS DERIVED FROM TUMOR FREE BONE-MARROW OF HODGKIN-DISEASE PATIENTS CAN HARBOR HIDDEN PRE-TUMOR CELLS, Experimental hematology, 25(8), 1997, pp. 69-69
IS GBV-C HGV ASSOCIATED WITH HEMATOLOGICAL MALIGNANCIES/
Authors: EDER G PAVLOVA BG SELIM U TUCHLER H HEINZ R PITTERMANN E
Citation: G. Eder et al., IS GBV-C HGV ASSOCIATED WITH HEMATOLOGICAL MALIGNANCIES/, Hepatology, 26(4), 1997, pp. 1495-1495
COMPARISON OF PROGNOSTIC SCORES IN MDS CONFIRMS IMPACT OF CYTOGENETICS
Authors: PFEILSTOCKER M REISNER R NOSSLINGER T GRUNER H NOWOTNY H SCHLOGL E TUCHLER H PITTERMANN E HEINZ R
Citation: M. Pfeilstocker et al., COMPARISON OF PROGNOSTIC SCORES IN MDS CONFIRMS IMPACT OF CYTOGENETICS, Blood, 90(10), 1997, pp. 2314-2314
PACLITAXEL IN THE SALVAGE TREATMENT OF HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
Authors: HOPFINGER G HEINZ R PFEILSTOCKER M SCHLOGL E WALDNER R PITTERMANN E
Citation: G. Hopfinger et al., PACLITAXEL IN THE SALVAGE TREATMENT OF HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(4), 1996, pp. 423-424
EXPRESSION OF G-ALPHA-16, A G-PROTEIN ALPHA-SUBUNIT SPECIFIC FOR HEMATOPOIESIS IN ACUTE-LEUKEMIA
Authors: PFEILSTOCKER M KARLIC HI SALAMON J KROMER E MUHLBERGER H PAVLOVA B SELIM U TUCHLER H FRITSCH G KNEISSL S HEINZ R PITTERMANN E PAUKOVITS WR
Citation: M. Pfeilstocker et al., EXPRESSION OF G-ALPHA-16, A G-PROTEIN ALPHA-SUBUNIT SPECIFIC FOR HEMATOPOIESIS IN ACUTE-LEUKEMIA, Leukemia, 10(7), 1996, pp. 1117-1121
THE HEMATOPOIESIS SPECIFIC G-PROTEIN ALPHA-SUBUNIT G-ALPHA-16 IS A MARKER OF EARLY NORMAL AND MALIGNANT HEMATOPOIESIS
Authors: PFEILSTOCKER M KARLIC H SALAMON J KROMER E MUHLBERGER H PAVLOVA B SELIM U FRITSCH G HEINZ R PITTERMANN E PAUKOVITS WR
Citation: M. Pfeilstocker et al., THE HEMATOPOIESIS SPECIFIC G-PROTEIN ALPHA-SUBUNIT G-ALPHA-16 IS A MARKER OF EARLY NORMAL AND MALIGNANT HEMATOPOIESIS, Blood, 88(10), 1996, pp. 3207-3207
G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL
Authors: LINK H WANDT H SCHONROCKNABULSI P EHNINGER G FRANKE A GACKLE R GEER T STROBEL G LINKESCH W KRIEGER O NIEDERWIESER D NIKIFORAKIS E OHL S OTREMBA B PITTERMANN E SCHMIDT H TISCHLER J WEISS J WILHELM M BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654
EXPERIENCE WITH ANTIRHESUS-D-THERAPY IN P RETREATED PATIENTS SUFFERING FROM IDIOPATHIC THROMBOCYTOPENIA
Authors: PFEILSTOCKER M WALDNER R REISNER R HEINZ R PITTERMANN E
Citation: M. Pfeilstocker et al., EXPERIENCE WITH ANTIRHESUS-D-THERAPY IN P RETREATED PATIENTS SUFFERING FROM IDIOPATHIC THROMBOCYTOPENIA, Infusionstherapie und Transfusionsmedizin, 22(4), 1995, pp. 220-224
FMS HEMIZYGOSITY IN MYELOID DYSPLASIA AND ACUTE MYELOID-LEUKEMIA WITHCHROMOSOMAL ABERRATION DEL(5)(Q) DEMONSTRATED BY POLYMERASE CHAIN-REACTION
Authors: PFEILSTOCKER M GRILL R KOLLER E KRIEGER O PITTERMANN E KARLIC H
Citation: M. Pfeilstocker et al., FMS HEMIZYGOSITY IN MYELOID DYSPLASIA AND ACUTE MYELOID-LEUKEMIA WITHCHROMOSOMAL ABERRATION DEL(5)(Q) DEMONSTRATED BY POLYMERASE CHAIN-REACTION, Journal of molecular medicine, 73(8), 1995, pp. 403-407
EARLY DETECTION OF MINIMAL RESIDUAL DISEASE BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION PREDICTS RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: KOLLER E KARLIC H KRIEGER O MISTRIK M GADNER H LUTZ D HEINZ R MICHLMAYR G PITTERMANN E
Citation: E. Koller et al., EARLY DETECTION OF MINIMAL RESIDUAL DISEASE BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION PREDICTS RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA, Annals of hematology, 70(2), 1995, pp. 75-78
IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE (VIM) AS SALVAGE THERAPY OF LOW TOXICITY IN NON-HODGKINS-LYMPHOMA
Authors: HOPFINGER G HEINZ R KOLLER E SCHNEIDER B PITTERMANN E
Citation: G. Hopfinger et al., IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE (VIM) AS SALVAGE THERAPY OF LOW TOXICITY IN NON-HODGKINS-LYMPHOMA, European journal of haematology, 55(4), 1995, pp. 223-227
LONG-TERM FOLLOW-UP OF 1,654 CONSECUTIVE NON-HODGKIN-LYMPHOMA PATIENTS - DATA FROM A SINGLE INSTITUTION
Authors: HEINZ R FORTELNY A SCHNEIDER B HOPFINGER G WOREL N MOSTL M WALDNER R TUCHLER H PITTERMANN E HANAK H
Citation: R. Heinz et al., LONG-TERM FOLLOW-UP OF 1,654 CONSECUTIVE NON-HODGKIN-LYMPHOMA PATIENTS - DATA FROM A SINGLE INSTITUTION, Onkologie, 18(3), 1995, pp. 231-239
G-ALPHA-16 HAS DIFFERENT EXPRESSION KINETICS TO CD34
Authors: KARLIC H PFEILSTOCKER M MUHLBERGER H STROBL H PAUKOVITS W FRITSCH G SALAMON J PITTERMANN E HEINZ R
Citation: H. Karlic et al., G-ALPHA-16 HAS DIFFERENT EXPRESSION KINETICS TO CD34, Experimental hematology, 23(8), 1995, pp. 811-811
ANALYSIS OF PERIPHERAL-BLOOD PROGENITOR CELLS DEMONSTRATES LIMITATIONS OF MINIMAL RESIDUAL DISEASE DIAGNOSIS IN A CASE OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: KARLIC HI MUHLBERGER H PAVLOVA BG PFEILSTOCKER M SALAMON J PITTERMANN E HEINZ R KOLLER E
Citation: Hi. Karlic et al., ANALYSIS OF PERIPHERAL-BLOOD PROGENITOR CELLS DEMONSTRATES LIMITATIONS OF MINIMAL RESIDUAL DISEASE DIAGNOSIS IN A CASE OF ACUTE PROMYELOCYTIC LEUKEMIA, Bone marrow transplantation, 15(6), 1995, pp. 999-1000
LONG-TERM OBSERVATION OF LYMPHOPLASMOCYTO ID IMMUNOCYTOMA
Authors: HEINZ R HOPFINGERLIMBERGER G PITTERMANN E
Citation: R. Heinz et al., LONG-TERM OBSERVATION OF LYMPHOPLASMOCYTO ID IMMUNOCYTOMA, Deutsche Medizinische Wochenschrift, 119(43), 1994, pp. 1487-1487
Risultati: 1-20 |